HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Perez, M. Articles by de la Torre, J. C. Search for Related Content PubMed PubMed Citation Articles by Perez, M. Articles by de la Torre, J. C. Agricola Articles by Perez, M. Articles by de la Torre, J. C.

Identification of the Borna disease virus (BDV) proteins required for the formation of BDV-like particles

The Scripps Research Institute, Department of Neuropharmacology IMM-6, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA

Correspondence
Juan Carlos de la Torre
juanct{at}scripps.edu

Borna disease virus (BDV) is an enveloped virus with a non-segmented, negative-strand RNA genome that has an organization characteristic of Mononegavirales. However, based on its unique genetics and biological features BDV is considered to be the prototypic member of a new virus family, Bornaviridae. Here, the use of a reverse genetic approach to identify the viral proteins required for packaging of BDV RNA analogues (MG) into infectious virus-like particles (VLPs) was described. Plasmids encoding individual BDV proteins under the control of a RNA polymerase II promoter were co-transfected with a plasmid that allows for intracellular synthesis of a BDV MG mediated by the cellular RNA polymerase I. Clarified lysates from transfected cells were passaged onto fresh cells that were previously transfected with plasmids expressing the minimal BDV trans-acting factors L, N and P required for RNA synthesis mediated by the BDV polymerase. Reconstitution of BDV MG-specific packaging and passage of infectious VLP was monitored by expression of the chloramphenicol acetyl transferase reporter gene present in the BDV MG. BDV M and G, in addition to L, N and P, were sufficient for the passage of chloramphenicol acetyl transferase activity, which could be blocked by BDV neutralizing antibodies to G, indicating that VLP infectivity was fully mediated by BDV G. Passage of BDV MG was abrogated by omission of either M or G.

This article has been cited by other articles:

				R. Clemente and J. C. de la Torre Cell-to-Cell Spread of Borna Disease Virus Proceeds in the Absence of the Virus Primary Receptor and Furin-Mediated Processing of the Virus Surface Glycoprotein J. Virol., June 1, 2007; 81(11): 5968 - 5977. [Abstract] [Full Text] [PDF]

				T. Hoenen, A. Groseth, L. Kolesnikova, S. Theriault, H. Ebihara, B. Hartlieb, S. Bamberg, H. Feldmann, U. Stroher, and S. Becker Infection of Naive Target Cells with Virus-Like Particles: Implications for the Function of Ebola Virus VP24 J. Virol., July 15, 2006; 80(14): 7260 - 7264. [Abstract] [Full Text] [PDF]

				M. Schwardt, D. Mayer, R. Frank, U. Schneider, M. Eickmann, O. Planz, T. Wolff, and M. Schwemmle The negative regulator of Borna disease virus polymerase is a non-structural protein J. Gen. Virol., November 1, 2005; 86(11): 3163 - 3169. [Abstract] [Full Text] [PDF]